PITFALLS IN THE DIAGNOSIS OF MEDICAL I HAVE NOTHING TO LIVER - - PowerPoint PPT Presentation

pitfalls in the diagnosis of medical i have nothing to
SMART_READER_LITE
LIVE PREVIEW

PITFALLS IN THE DIAGNOSIS OF MEDICAL I HAVE NOTHING TO LIVER - - PowerPoint PPT Presentation

5/26/2017 CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017 PITFALLS IN THE DIAGNOSIS OF MEDICAL I HAVE NOTHING TO LIVER DISEASE WITH TWO DISCLOSE CONCURRENT ETIOLOGIES Linda Ferrell Linda Ferrell, MD, UCSF Entities such as non-alcoholic


slide-1
SLIDE 1

5/26/2017 1

I HAVE NOTHING TO DISCLOSE

Linda Ferrell

CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017

PITFALLS IN THE DIAGNOSIS OF MEDICAL LIVER DISEASE WITH TWO CONCURRENT ETIOLOGIES

Linda Ferrell, MD, UCSF

IDEAL versus REAL

IDEAL = one disease only to consider REAL = more than one entity is increasingly of concern

THE PROBLEM for liver pathology in 2017

Entities such as non-alcoholic steatohepatitis and

HCV are relatively common

Many patients with chronic liver disease history are

living longer due to more advanced therapies (HCV, HBV, PBC)

Risk of acquiring a 2nd etiology is likely increased

  • ver time

Separation of entities enables better treatment with

etiology- specific therapies

slide-2
SLIDE 2

5/26/2017 2

Major Patterns of Disease: Portal-based Injury typically in portal/periportal areas

Chronic viral hepatitis, other chronic hepatitides HBV, HCV, alpha-1-antitrypsin, Wilson’s, AIH Biliary tract obstructive disease: Obstruction, primary biliary cholangitis, primary sclerosing

cholangitis

Hemochromatosis

Portal Based: Chronic Hepatitis

Portal-Based: Chronic biliary disease (PBC) with ductular reaction in portal zones

slide-3
SLIDE 3

5/26/2017 3

Portal-based: Hemochromatosis

Iron overload begins in periportal zone. Results in periportal fibrosis due to FE toxicity

Major Patterns of Disease: Central-based Injury typically in centrizonal areas

Steatohepatitis Nonalcoholic (NASH), Alcoholic Chronic ischemic injury and/or chronic vascular

  • utflow obstruction

Budd-Chiari syndrome, congestive heart failure Some mild to moderate acute drug/toxic

injuries

Acetaminophen, mushroom toxicity

NASH, Trichrome: Centrizonal NASH, Trichrome: Centrizonal NASH, Trichrome: Centrizonal NASH, Trichrome: Centrizonal pericellular and sinusoidal fibrosis pericellular and sinusoidal fibrosis pericellular and sinusoidal fibrosis pericellular and sinusoidal fibrosis

Central-based: Chronic Venous Outflow Obstruction

Chronic Heart Failure Chronic Budd Chiari Syndrome

slide-4
SLIDE 4

5/26/2017 4

Central based: Toxic (one-hit) event Example: Acetaminophen

Centrizonal necrosis

Central-Based Pattern: Pitfalls

Chronic changes of centrizonal region that can mimic portal tracts, so called “portalization of central zones”

Arterialization within centrizonal scar Ductular reaction/metaplasia of injured

hepatocytes and/or progenitor cells NASH, Trichrome: Centrizonal Fibrosis (1b) NASH, Trichrome: Centrizonal Fibrosis (1b) NASH, Trichrome: Centrizonal Fibrosis (1b) NASH, Trichrome: Centrizonal Fibrosis (1b)

Artery

DON’T CONFUSE WITH PORTAL ZONE

Central Vein Arrows highlight centrizonal arteries

slide-5
SLIDE 5

5/26/2017 5

Budd-Chiari Syndrome: Centrizonal Fibrosis and Ductular Metaplasia

DON’T CONFUSE WITH PORTAL ZONE

Acute or Chronic Injury

Major Patterns:

Hepatocyte panlobular injury Inflammatory (hepatitic) panlobular Necrotic panlobular Fatty change Alcohol, Non-alcoholic steatohepatitis, other causes Fibrosis versus Necrosis Biggest issue is CIRRHOSIS versus SEVERE ACTIVE HEPATITIS

with regenerative nodules and intervening necrosis

Hepatocytic Panlobular Injury

Inflammatory (hepatitic) panlobular

ACUTE hepatitis (Notable examples: HAV, HEV, AIH,

idiosyncratic drug or “herbal” reactions)

Ongoing/active chronic hepatitis (Examples: AIH,

HBV, HCV)

Necrotic panlobular: acute injury with minimal

inflammation

Toxic (one-hit, as with acetaminophen) Ischemic (Example: shock)

Combination of Inflammatory and Necrotic

SEVERE acute to subacute hepatitis (more variable

stages of necrosis + inflammatory changes usually with ductular reaction)

slide-6
SLIDE 6

5/26/2017 6

Fibrosis versus Necrosis

Routine histochemical stains can be helpful

Trichrome: Two-toned color and two textures Scar: darker blue color and dense fibers Necrosis: Lighter blue color and more delicate fibers Reticulin: collapsed or not Orcein/EVG: Used for elastic fibers: formation starts

about 12 weeks after injury

Ferrell L, Greenberg M. Special Stains Can Distinguish Hepatic Necrosis with Regenerative Nodules from Cirrhosis Liver International 27:681- 686, 2007.

Severe Acute Hepatitis, Inflammatory Pattern

Generally presents as fulminant liver failure Typically correlates with submassive to massive necrosis of the liver

Early stage — necrosis, Kupffer cell reaction Subacute stage — hepatocyte regeneration, early

collapse of reticulin framework

Late stage — nodule formation; fibrosis and/or

cirrhosis

EARLY Severe Acute Hepatitis: Necrosis and Kupffer Cell Reaction

Panlobular necrosis and congestion Immunostain for CD68 to confirm as Kupffer cells

EARLY Severe Acute Hepatitis: Necrosis and Kupffer Cell Reaction

Trichrome: No hepatocytes; Centrilobular zone, two colors and textures

Reticulin stain: Centrilobular zone, framework still intact

Light and delicate = necrosis

Dark and Dense = Normal structures or scar Intact plates, No necrosis Intact plates: Necrosis

slide-7
SLIDE 7

5/26/2017 7

Subacute Severe Hepatitis: Regeneration and collapse

Nodular regeneration, congestion of necrotic centrilobular zones Reticulin stain: Collapse of framework between regenerative nodules

Collapse: Thinner plates, wavy fibers Regenerative nodule Congested central zone

Subacute Severe Hepatitis

Trichrome stain:

Lighter blue with congestion, ductular reaction = zones of recent necrosis NODULAR regeneration and DUCTULAR REACTION indicates subacute process

Late Stage: Established Cirrhosis

Trichrome: Dark, dense blue scar Trichrome: Dark, dense blue scar

Late Stage: Established Cirrhosis

Orcein: Elastic (black) fibers as sign of chronicity Orcein: Elastic fibers in Cirrhosis

slide-8
SLIDE 8

5/26/2017 8

In contrast: Acute Necrosis, <12 weeks in duration

Orcein: Elastic (black) fibers present in residual portal tracts and central veins; ductular reaction present

In contrast: Subacute injury approaching 12 weeks

Orcein: Elastic (black) fibers limited to portal zones, central veins; rare small fibers in early scar

Regenerative nodule

Late Stage: Established Cirrhosis

Trichrome: Dark, dense blue scar and pale grey zones (Elastic fibers) Elastic (EVG) stain: Black elastic fibers

Late Stage: Established Cirrhosis

Trichrome: Dark, dense blue scar and pale grey zones (Elastic fibers) Elastic (EVG) stain: Black elastic fibers Orcein stain: Black elastic fibers

slide-9
SLIDE 9

5/26/2017 9

Question: Fibrosis or Necrosis

Is this centrizonal fibrosis or necrosis on trichrome stain?

  • A. Fibrosis
  • B. Necrosis

F i b r

  • s

i s N e c r

  • s

i s

88% 12%

Mixed etiology: Acute on Chronic

CASE 1

31 year old man, history of ulcerative colitis Clinical diagnosis of primary sclerosing cholangitis

in 2001, no liver biopsy

No signs of cirrhosis 3 months prior to his

presentation of subacute liver failure with high levels AST, ALT

Transplanted at UCSF Clinical diagnosis: Possibly end-stage PSC, but an

unusual rapid hepatitic pattern of progression over 3 months

Acute on Chronic

Large zones of panacinar necrosis, with ductular reaction and inflammatory infiltrates

Acute on Chronic

Trichome: zones of collapse, but no dark bands of fibrosis Trichrome stain: Two toned, light and dark

slide-10
SLIDE 10

5/26/2017 10

Acute on Chronic

Focal regenerative nodules Trichrome: No fibrosis

Acute on Chronic

ORCEIN: no elastosis

Acute on Chronic

Trichrome: Hilar duct sclerosis Periduct sclerosis

Question: What is your best diagnosis?

  • A. Cirrhosis due to HCV and primary sclerosing

cholangitis (PSC)

  • B. Acute hepatitis and PSC
  • C. Chronic hepatitis C and PSC
  • D. Fatty liver disease (NASH) and PSC

C i r r h

  • s

i s d u e t

  • H

C V a n d . . . A c u t e h e p a t i t i s a n d P S C C h r

  • n

i c h e p a t i t i s C a n d P S C F a t t y l i v e r d i s e a s e ( N A S . .

0% 3% 3% 93%

slide-11
SLIDE 11

5/26/2017 11

Mixed Etiology: Acute on Chronic

DIAGNOSES

Chronic changes of early stage PSC Periduct fibrosis and hilar duct sclerosis Superimposed acute hepatitis of unknown etiology Zones of panacinar necrosis, without fibrosis

Mixed etiology: Acute on Chronic

Case 2

50 year old obese man, diabetic and heavy drinker No previous liver biopsy Presented in liver failure and ascites for liver

transplantation

Clinical diagnosis: End-stage liver disease, possibly

due to severe steatohepatitis

Case courtesy of Dr A Paul Dhillon, Royal Free Hospital, London

Acute on Chronic

Trichrome: nodular, with necrosis, two toned Focal bridging fibrosis involving centrizonal areas, mild fatty change

Acute on Chronic

Two toned; and swollen, ballooned hepatocytes Two toned; with ductular reaction, focal fat, ballooned hepatocytes

slide-12
SLIDE 12

5/26/2017 12

Acute on Chronic: Regenerative nodule

Acute on Chronic: Inflammation

Question: What is your best diagnosis?

  • A. End-stage cirrhosis due to steatohepatitis
  • B. Steatohepatitis with fibrosis, with overlying

acute injury

E n d

  • s

t a g e c i r r h

  • s

i s d u e t

  • .

. . S t e a t

  • h

e p a t i t i s w i t h f i b r

  • .

. .

98% 2%

Mixed etiology: Acute on Chronic

Chronic steatohepatitis with bridging fibrosis,

indistinguishable for NASH or ASH

Overlying acute hepatitis, not specific for etiology,

plasma cells seen

Differential diagnosis: AIH, Drug, HAV, HEV Workup: negative for autoimmune markers, HAV, and

drug/herbal/other nutritional agents

Final Diagnosis:

Hepatitis E (HEV) and chronic steatohepatitis

slide-13
SLIDE 13

5/26/2017 13

Acute on Chronic: Same Disease

Usual suspects

AIH, more common in

women

Excerbation of HBV Wilsons disease in

younger patients

Example: Wilsons Disease

Mixed Etiology: Chronic on Chronic

Most commonly: NASH + HCV or HBV

Prominent chronic inflammation in NASH may suggest

superimposed viral or other hepatitis/inflammatory process, but scattered plasma cells normal in NASH

CAVEAT: Chronic inflammation can be increased and fat

may be decreased in Stage 3-4 NASH

NASH + HCV or HBV

NOTE pattern of disease locations PORTAL: favors chronic hepatitis

Portal-based chronic inflammation, fibrosis, and

interface hepatitis

HBV or HCV markers

CENTRAL: favors steatohepatitis

Centrizonal fat, fibrosis, ballooned cells, inflammation

associated with fat

Risk factors for NASH/ASH

NASH and HCV

Centrizonal and Periportal fibrosis

slide-14
SLIDE 14

5/26/2017 14

NASH and HCV

Centrizonal and Periportal fibrosis

How to stage?

NASH + HCV or HBV STAGING

For earlier stages, stage separately, if possible

NASH: Brunt or Kleiner stage

Case example

if all fibrosis due to NASH, Stage 2 NASH If periportal likely due to HCV, then Stage 1 NASH Viral hepatitis: Do not include central fibrosis Note prominent pattern or combination of patterns as

centrizonal or portal if possible

NASH and HCV, stage 4

NASH and HCV

Lymphocytic infiltrate could be HCV Ballooned Hepatocytes, mild fat

slide-15
SLIDE 15

5/26/2017 15

NASH and HCV, cirrhosis

How to stage for late stages?

NASH + HCV or HBV STAGING

Later stages: Stage combined etiologic patterns as

bridging fibrosis or cirrhosis

Stage 3 or 4 Note if both centrizonal, portal patterns are present,

and if possible, most prominent pattern

Note any difficulties of determining etiologic cause of

all fibrosis to communicate the message that both entities could have contributed to stage

Mixed Etiology: Chronic on Chronic

Case 3

58 year old obese woman with diabetes Followed for NASH for 5 years Presents now with elevated alkaline phosphatase

and itching

Liver biopsy performed at UCSF

Chronic on Chronic

Classic centrizonal NASH changes: Fat, Ballooned heaptocytes

Trichrome stain: Centrizonal, pericellular fibrosis

slide-16
SLIDE 16

5/26/2017 16

Chronic on Chronic

Trichrome: Central to central bridging fibrosis typical

  • f stage 3 NASH

Chronic on Chronic

Trichrome: Left: Central fibrosis Right: periportal fibrosis with prominent inflammatory nodule

Chronic on Chronic

PORTAL : Lymphoid aggregate and granulomatous infiltrate, plus damaged dilated duct

Chronic on Chronic

PORTAL : Granulomatous infiltrate extending into lobule, plus duct loss

slide-17
SLIDE 17

5/26/2017 17

Question: What is your best Diagnosis?

  • A. NASH and HCV
  • B. NASH and primary sclerosing cholangitis
  • C. Fatty liver without NASH, and sarcoidosis
  • D. NASH and primary biliary cholangitis

N A S H a n d H C V N A S H a n d p r i m a r y s c l e r

  • .

. . F a t t y l i v e r w i t h

  • u

t N A S H . . . N A S H a n d p r i m a r y b i l i a r y . . .

14% 74% 2% 10%

Mixed etiology: Chronic on Chronic

Granulomatous infiltrates and duct injury/loss not

typical of NASH, suggesting primary biliary cholangitis

Patient found to have high titers AMA

Final Diagnoses:

Chronic steatohepatitis with bridging fibrosis Overlying primary biliary cholangitis (PBC),

formerly known as primary biliary cirrhosis, early stage

Take home messages

Recognize Major Patterns of Disease Portal-based, Central-based, Acute vs Chronic Use special stains to recognize Acute versus Chronic Trichrome, Reticulin, Elastic stain Importance of clinical correlation Includes history of duration of illness, therapies/drug

exposures, risk factors for common liver diseases, and laboratory workup